BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23071491)

  • 1. Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs.
    Leuchs S; Saalfrank A; Merkl C; Flisikowska T; Edlinger M; Durkovic M; Rezaei N; Kurome M; Zakhartchenko V; Kessler B; Flisikowski K; Kind A; Wolf E; Schnieke A
    PLoS One; 2012; 7(10):e43323. PubMed ID: 23071491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine model elucidates function of p53 isoform in carcinogenesis and reveals novel circTP53 RNA.
    Niu G; Hellmuth I; Flisikowska T; Pausch H; Rieblinger B; Carrapeiro A; Schade B; Böhm B; Kappe E; Fischer K; Klinger B; Steiger K; Burgkart R; Bourdon JC; Saur D; Kind A; Schnieke A; Flisikowski K
    Oncogene; 2021 Mar; 40(10):1896-1908. PubMed ID: 33603167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and translational imaging of a TP53 porcine tumorigenesis model.
    Sieren JC; Meyerholz DK; Wang XJ; Davis BT; Newell JD; Hammond E; Rohret JA; Rohret FA; Struzynski JT; Goeken JA; Naumann PW; Leidinger MR; Taghiyev A; Van Rheeden R; Hagen J; Darbro BW; Quelle DE; Rogers CS
    J Clin Invest; 2014 Sep; 124(9):4052-66. PubMed ID: 25105366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A porcine model of osteosarcoma.
    Saalfrank A; Janssen KP; Ravon M; Flisikowski K; Eser S; Steiger K; Flisikowska T; Müller-Fliedner P; Schulze É; Brönner C; Gnann A; Kappe E; Böhm B; Schade B; Certa U; Saur D; Esposito I; Kind A; Schnieke A
    Oncogenesis; 2016 Mar; 5(3):e210. PubMed ID: 26974205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viable pigs with a conditionally-activated oncogenic KRAS mutation.
    Li S; Edlinger M; Saalfrank A; Flisikowski K; Tschukes A; Kurome M; Zakhartchenko V; Kessler B; Saur D; Kind A; Wolf E; Schnieke A; Flisikowska T
    Transgenic Res; 2015 Jun; 24(3):509-17. PubMed ID: 25716163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
    Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
    Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.
    Shen Y; Xu K; Yuan Z; Guo J; Zhao H; Zhang X; Zhao L; Qing Y; Li H; Pan W; Jia B; Zhao HY; Wei HJ
    J Transl Med; 2017 Nov; 15(1):224. PubMed ID: 29100547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells.
    Rodriguez R; Rubio R; Masip M; Catalina P; Nieto A; de la Cueva T; Arriero M; San Martin N; de la Cueva E; Balomenos D; Menendez P; García-Castro J
    Neoplasia; 2009 Apr; 11(4):397-407. PubMed ID: 19308294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of
    Na B; Yu X; Withers T; Gilleran J; Yao M; Foo TK; Chen C; Moore D; Lin Y; Kimball SD; Xia B; Ganesan S; Carpizo DR
    NPJ Breast Cancer; 2019; 5():14. PubMed ID: 30993195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression.
    Vinall RL; Chen JQ; Hubbard NE; Sulaimon SS; Shen MM; Devere White RW; Borowsky AD
    Dis Model Mech; 2012 Nov; 5(6):914-20. PubMed ID: 22563073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis.
    Tsang WP; Ho FY; Fung KP; Kong SK; Kwok TT
    Int J Cancer; 2005 Apr; 114(3):331-6. PubMed ID: 15578696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system.
    Shintani Y; Yotsuyanagi H; Moriya K; Fujie H; Tsutsumi T; Kanegae Y; Kimura S; Saito I; Koike K
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3257-3265. PubMed ID: 10567659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
    Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
    Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a two-base insertion mutation of the
    Asada H; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H
    Am J Vet Res; 2019 Jul; 80(7):680-688. PubMed ID: 31246118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of interactions between p53 and survivin gene in mesenchymal stem cells after spontaneous transformation in vitro.
    He L; Zhao F; Zheng Y; Wan Y; Song J
    Int J Biochem Cell Biol; 2016 Jun; 75():74-84. PubMed ID: 27046449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene targeting by homologous recombination in fish ES cells.
    Yan Y; Hong N; Chen T; Li M; Wang T; Guan G; Qiao Y; Chen S; Schartl M; Li CM; Hong Y
    PLoS One; 2013; 8(3):e59400. PubMed ID: 23527183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.
    Nakayama M; Hong CP; Oshima H; Sakai E; Kim SJ; Oshima M
    Nat Commun; 2020 May; 11(1):2333. PubMed ID: 32393735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma.
    Stokke T; Galteland E; Holte H; Smedshammer L; Suo Z; Smeland EB; Børresen-Dale AL; DeAngelis P; Steen HB
    Int J Cancer; 2000 Jul; 89(4):313-24. PubMed ID: 10956404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.